Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID07341997

Environmental Factors Associated With Peripheral Neuropathies in French Guiana

Led by Admin CIC · Updated on 2026-01-15

78

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Peripheral neuropathies (PN) affect about 1% of people worldwide, especially older adults, causing problems with walking and chronic pain that reduce quality of life. In French Guiana, researchers think that unknown causes of PN may be linked to exposure to neurotoxic traditional plant remedies, arboviral infections like Zika, Chikungunya, and Dengue, and mercury contamination from illegal gold mining. This study aims to explore how these environmental factors relate to PN, including in people with diabetic neuropathy or chronic idiopathic axonal polyneuropathy. This is a prospective multicenter case-control study conducted at hospitals in Cayenne and Saint-Laurent du Maroni. Participants include patients with diagnosed diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy, and a control group of hospital patients without neuropathy. At the initial visit, blood, urine, and hair samples will be collected to test for arbovirus antibodies and measure heavy metals like mercury and lead. Participants will also complete a questionnaire about their use of traditional plants. Participants will not have follow-up visits as part of the study. The main outcome measured is the comparison of exposure rates to these environmental factors between the case and control groups. Additional assessments include identifying genetic mutations and determining peripheral nerve disability at the time of enrollment. The study will help understand environmental risks that might explain unexplained cases of PN in this region.

CONDITIONS

Brief Title

Environmental Factors Associated With Peripheral Neuropathies in French Guiana

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy (Case group)
  • Patients hospitalized or consulting at hospitals in Cayenne and Saint-Laurent du Maroni without peripheral neuropathy (Control group)
  • Age 18 years or older
  • Ability to complete the study questionnaire
  • Willingness to participate without objection
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Objecting to participation
  • Unable to complete the questionnaire

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Inclusion Visit

Duration - 1 day

Participants provide blood, urine, and hair samples and complete a questionnaire about plant consumption to assess environmental exposures related to peripheral neuropathies.

1 visit (in-person)

Trial Site Locations

Total: 2 locations

1

Centre Hospitalier de Cayenne

Cayenne, French Guiana, 97300

Actively Recruiting

2

Centre Hospitalier de l'Ouest Guyanais

Saint-Laurent-du-Maroni, French Guiana, 97320

Actively Recruiting

Loading map...

Research Team

N

Nathalie DESCHAMPS, Principal Investigator

V

Vincent De Paul SENEKIAN, Principal Investigator

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Balance4Mobility: Effects of Walkasins Use on Clinical Outco...

Peripheral Neuropathies

Actively Recruiting

6 locations

Feasibility Testing of a Virtual Tai Chi Program for Chemoth...

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Actively Recruiting

1 location

Neuropathy in Waldenstrm's Macroglobulinemia: Pathophysiolo...

Waldenstrom Macroglobulinaemia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Diabetes in French Guiana, adapting national standards of therapeutic education and care to the amazonian challenge.

Nadia Sabbah, Gabriel Carles, Magalie Demar...

https://pubmed.ncbi.nlm.nih.gov/33594330

Childhood lead exposure of Amerindian communities in French Guiana: an isotopic approach to tracing sources.

Laurence Maurice, Fiorella Barraza, Isalyne Blondet...

https://pubmed.ncbi.nlm.nih.gov/33974199

Frequency of exposure to arboviruses and characterization of Guillain Barré syndrome in a clinical cohort of patients treated at a tertiary referral center in Brasília, Federal District.

Luíza Morais de Matos, Ariely Teotonio Borges, Aline Barbosa Palmeira...

https://pubmed.ncbi.nlm.nih.gov/35416870

Mercury contamination levels in the bioindicator piscivorous fish Hoplias aïmara in French Guiana rivers: mapping for risk assessment.

Régine Maury-Brachet, Sophie Gentes, Emilie P Dassié...

https://pubmed.ncbi.nlm.nih.gov/30610584

Regional distribution of mercury in sediments of the main rivers of French Guiana (Amazonian basin).

Valérie Laperche, Jennifer Hellal, Régine Maury-Brachet...

https://pubmed.ncbi.nlm.nih.gov/25045610